Fortitude Family Office’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.21K Buy
77
+56
+267% +$6.78K ﹤0.01% 861
2026
Q1
$3.43K Buy
21
+2
+11% +$307 ﹤0.01% 1074
2025
Q4
$3.31K Buy
19
+4
+27% +$730 ﹤0.01% 976
2025
Q3
$2.16K Buy
15
+5
+50% +$613 ﹤0.01% 1184
2025
Q2
$1.01K Buy
+10
New +$765 ﹤0.01% 1503
2025
Q1
– Sell
-7
Closed -$483 – 1222
2024
Q4
$483 Hold
7
– – ﹤0.01% 1218
2024
Q3
$511 Buy
+7
New +$517 ﹤0.01% 1161

Other funds holding INSM

Fortitude Family Office's INSM Position: Q2 2026 in Review

Fortitude Family Office increased its Insmed (INSM) stake by 267% in Q2 2026, buying an estimated $6.78K and bringing the position to 77 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Fortitude Family Office first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fortitude Family Office held 77 shares of Insmed worth $8.21K as of Q2 2026.
  • Fortitude Family Office bought 56 Insmed shares in Q2 2026, an estimated $6.78K.
  • Insmed made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #861 holding.
  • Fortitude Family Office first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.